Discover 1,918 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,918
Home With TablO outcoMEs (HOME) Registry
for
End Stage Renal Disease
Location: Plano TX, Lincoln NE, Helena MT, New York NY,
Sponsor: Outset Medical
Sex: All
Age: 15+
Code: NCT04526301
Recruiting
Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)
for
Metatarsus Adductus, Hallux Valgus
Location: Keller TX, Jefferson City MO, Ankeny IA, Greeley CO,
Sponsor: Treace Medical Concepts, Inc.
Sex: All
Age: 14 - 65
Code: NCT05587569
Recruiting
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
for
Atopic Dermatitis
Location: Fort Worth TX, Dallas TX, Pflugerville TX,
Sponsor: Sanofi
Sex: All
Age: 12+
Code: NCT07290803
Recruiting
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
for
Complex Regional Pain Syndrome Type I
Location: Fort Worth TX, Mesquite TX, Houston TX, Lubbock TX,
Sponsor: Ambros Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07210515
Phase3, Recruiting
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
for
Immunoglobulin G4 Related Disease
Location: Plano TX, Red Oak TX, Wichita Falls TX, Tustin CA,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07190196
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
for
Diffuse Cutaneous Systemic Sclerosis
Location: Allen TX, Dallas TX, Aurora CO, Clearwater FL, Tampa FL,
Sponsor: Mediar Therapeutics
Sex: All
Age: 18+
Code: NCT07287670
Phase2, Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
for
Agitation, Alzheimer Disease
Location: Plano TX, Round Rock TX, Austin TX, Cordova TN,
Sponsor: Celgene
Sex: All
Age: 55 - 70+
Code: NCT06808984
Phase2, Recruiting
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
for
SLE, SLE (Systemic Lupus)
Location: Plano TX, Webster TX, Memphis TN, Iowa City IA,
Sponsor: Cullinan Therapeutics Inc.
Sex: All
Age: 18 - 70
Code: NCT06613360
Phase1, Recruiting
Safety, Tolerability, PK, and Analgesic Effect of INL-001 in Children Following Open Inguinal Hernia Repair
for
Inguinal Hernia, Postoperative Pain
Location: Plano TX, Houston TX, Corpus Christi TX, El Paso TX,
Sponsor: Innocoll
Sex: All
Age: 2 - 16
Code: NCT03262688
Phase3, Recruiting
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
for
Peripheral Artery Disease (PAD)
Location: Plano TX, DeSoto TX, Oklahoma City OK, Shreveport LA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07318610
Phase3, Recruiting
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder
Location: Plano TX, Oklahoma City OK, Austin TX, Atlanta GA,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 0+
Code: NCT06480383
Phase2, Recruiting
A Five-Year Quality of Life Study for Cancer Patients
for
Cancer
Location: Grapevine TX
Sponsor: Constantine A. Kotsanis
Sex: All
Age: 18+
Code: NCT01539148
Recruiting
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
for
Transthyretin Amyloidosis With Cardiomyopathy
Location: Plano TX, Dallas TX, Houston TX, Kansas City KS,
Sponsor: Alnylam Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07052903
Phase3, Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease